Hongdi Ma
State Key Laboratory Of Immune Response And Immunotherapy
Hefei, 230027, China
Hefei, 230027, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Innate immunity in tumors: From mechanisms to therapeutics.
Journal: Chinese medical journal
Published: August 27, 2025
TIGIT-targeted IL-12 fusion protein engages NK and CD8+ T cells for potent tumor immunotherapy.
Journal: Cell reports. Medicine
Published: July 15, 2025
αTIGIT-IL2 achieves tumor regression by promoting tumor-infiltrating regulatory T cell fragility in mouse models.
Journal: Nature communications
Published: January 15, 2025
Histone lactylation-driven intratumoral IGFBP2+ NK cells promote tumor immune evasion.
Journal: Cell reports
Published: September 29, 2024
Blockade of CD300A enhances the ability of human NK cells to lyse hematologic malignancies.
Journal: Cancer biology & medicine
Published: March 01, 2024
Clinical immunotherapy in pancreatic cancer.
Journal: Cancer immunology, immunotherapy : CII
Published: October 07, 2023
Sphingomyelin is a prospective metabolic immune checkpoint for natural killer cells.
Journal: Clinical and translational medicine
Published: August 16, 2023
Intestinal Uptake and Tolerance to Food Antigens.
Journal: Frontiers in immunology
Published: March 28, 2022
Vitamin B5 rewires Th17 cell metabolism via impeding PKM2 nuclear translocation.
Journal: Cell reports
Published: March 08, 2022
T lymphocytes in the intestinal mucosa: defense and tolerance.
Journal: Cellular & molecular immunology
Published: July 28, 2018
The DNA Methylcytosine Dioxygenase Tet2 Sustains Immunosuppressive Function of Tumor-Infiltrating Myeloid Cells to Promote Melanoma Progression.
Journal: Immunity
Published: November 28, 2016
Last Updated: 09/26/2026